Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Micron Technology
MU
$1.03T
| $20.8M | 0.03% |
503,123
-1,232,324
| -71% | -$47.6M |
|
777
Lam Research
LRCX
$388B
| $20.8M | 0.03% |
1,159,260
+747,520
| +182% | +$12.5M |
|
778
BOK Financial
BOKF
$8.54B
| $20.7M | 0.03% |
254,262
+179,332
| +239% | +$15.1M |
|
779
American International
AIG
$40.5B
| $20.7M | 0.03% |
481,255
+192,424
| +67% | +$8.23M |
|
780
Helix Energy Solutions
HLX
$1.47B
| $20.6M | 0.03% |
2,603,190
-844,867
| -25% | -$6.05M |
|
|
781
CALL
Walt Disney
DIS
$191B
| $20.6M | 0.03% |
185,400
+169,800
| +1,088% | +$19M |
|
782
Penumbra
PEN
$12.8B
| $20.6M | 0.03% |
139,902
-34,771
| -20% | -$4.97M |
|
783
Usana Health Sciences
USNA
$252M
| $20.5M | 0.03% |
244,610
+130,657
| +115% | +$13.6M |
|
784
Veracyte
VCYT
$3.33B
| $20.5M | 0.03% |
819,227
-599,059
| -42% | -$11.4M |
|
785
PUT
Salesforce
CRM
$171B
| $20.5M | 0.03% |
129,400
+70,400
| +119% | +$10.9M |
|
786
Schneider National
SNDR
$6.11B
| $20.5M | 0.03% |
972,391
-417,310
| -30% | -$8.93M |
|
787
Cheniere Energy
LNG
$58B
| $20.5M | 0.03% |
299,402
-1,425,869
| -83% | -$93.7M |
|
788
Olin
OLN
$2B
| $20.3M | 0.03% |
879,228
-1,606,181
| -65% | -$38.4M |
|
789
PTC Therapeutics
PTCT
$5.93B
| $20.3M | 0.03% |
538,001
+374,690
| +229% | +$12.6M |
|
790
Hanover Insurance
THG
$7.92B
| $20.2M | 0.03% |
177,241
-11,259
| -6% | -$1.3M |
|
791
Cigna
CI
$74.1B
| $20.1M | 0.03% |
125,281
-504,457
| -80% | -$92.1M |
|
792
PENN Entertainment
PENN
$2.45B
| $20.1M | 0.03% |
1,001,667
+883,171
| +745% | +$20.7M |
|
793
Rayonier
RYN
$6.32B
| $20.1M | 0.03% |
703,442
+159,016
| +29% | +$4.24M |
|
794
CALL
Novartis
NVS
$300B
| $20.1M | 0.03% |
+232,909
| New | +$18.7M |
|
795
Bank of Hawaii
BOH
$3.03B
| $20M | 0.03% |
253,720
+187,482
| +283% | +$14.7M |
|
|
DHR.PRA
796
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $19.9M | 0.03% |
+18,963
| New | +$19.6M |
|
797
Brunswick
BC
$5.26B
| $19.9M | 0.03% |
395,927
+325,861
| +465% | +$16.4M |
|
798
PUT
State Street Energy Select Sector SPDR ETF
XLE
$41.5B
| $19.8M | 0.03% |
+600,000
| New | +$19.3M |
|
799
Pacific Biosciences
PACB
$398M
| $19.7M | 0.03% |
2,730,462
+64,374
| +2% | +$466K |
|
800
Fair Isaac
FICO
$25.2B
| $19.7M | 0.03% |
72,433
-90,027
| -55% | -$21.2M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.